Nascent Biotech News - Nascent Biotech

Products
Investors
- Corporate Governance
- Contact Investor Relations
News
About
Contact

Products
Investors
- Corporate Governance
- Contact Investor Relations
News
About
Contact

Nascent Biotech News

antibody-600

AccessWire Feed

Nascent Biotech Press Releases

VIDEO: Nascent Biotech CEO Sean Carrick at the Emerging Grown Conference

VIDEO: Nascent Biotech CEO Sean Carrick at the Emerging Grown Conference

September 10, 2024 Corporate News, News, Science News

Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run

Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run

April 16, 2024 Corporate News, Press Releases, Science News

Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates

Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates

February 6, 2024 Corporate News, Press Releases, Science News

Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued

Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued

January 9, 2024 Corporate News

Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk

Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk

December 19, 2023 Uncategorized

Delivering human antibodies for the treatment of cancer

© NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.